BackQ32 Bio Overview

Q32 Bio Total Assets

Latest total assets for QTTB: $120M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$115.87M
↑ 75.25% YoYΔ $49.75M vs prior year quarter

Peer average / median

Loading

Q32 Bio Total Assets History

Loading

Q32 Bio vs. peers: Total Assets Comparison

Loading

Q32 Bio Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Q32 Bio (QTTB) FAQ

As of the most recent data (June 2026), QTTB shows a total assets of $120M. That compares with $66M in the prior-year period — up 75.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, QTTB's total assets is now $120M (was $66M) — a 75.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Q32 Bio is outperforming or lagging.

Tracking QTTB's total assets over time shows whether Q32 Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $120M That compares with $66M in the prior-year period — up 75.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Q32 Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $120M) with ownership activity and broader fundamentals.

Q32 Bio's total assets is $120M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.